quinazolines has been researched along with Absence Status in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Benninger, F; Lenz, M; Maggio, N; Neufeld, MY; Shavit-Stein, E; Shimon, MB; Vlachos, A | 1 |
| Fu, J; Li, ZY; Lu, J; Luo, XM; Wu, WY; Zhang, M; Zhao, J | 1 |
| Al Kury, LT; Bogovyk, R; Fedoriuk, M; Isaeva, E; Krishtal, O; Nikolaienko, O; Savotchenko, A; Semenikhina, M | 1 |
| Diaz-Hernandez, M; Engel, T; Henshall, DC; Hessel, EV; Jimenez-Pacheco, A; Mesuret, G; Miras-Portugal, MT; Sanz-Rodriguez, A | 1 |
| Holmes, GL; Isaev, D; Isaeva, E; Lunko, O; Lushnikova, I; Maximyuk, O; Romanov, A; Skibo, GG; Tian, C; Zapukhliak, O | 1 |
| Bogovyk, R; Fedoriuk, M; Holmes, GL; Isaev, D; Isaeva, E; Krishtal, O; Lunko, O | 1 |
| Cavalheiro, EA; da Silva Fernandes, MJ; Doná, F; Ferreira, AT; Vianna, EP | 1 |
7 other study(ies) available for quinazolines and Absence Status
| Article | Year |
|---|---|
Systemic thrombin inhibition ameliorates seizures in a mouse model of pilocarpine-induced status epilepticus.
Topics: Animals; Anticoagulants; Disease Models, Animal; Hippocampus; Male; Mice; Pilocarpine; Pyrroles; Quinazolines; Receptor, PAR-1; Status Epilepticus; Thrombin | 2019 |
Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice.
Topics: Animals; Benzodioxoles; Cognition; Cognitive Dysfunction; Enzyme Inhibitors; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neurons; Proto-Oncogene Proteins c-fyn; Quinazolines; Status Epilepticus | 2021 |
Inhibition of protease-activated receptor 1 ameliorates behavioral deficits and restores hippocampal synaptic plasticity in a rat model of status epilepticus.
Topics: Animals; Behavior, Animal; CA1 Region, Hippocampal; Disease Models, Animal; Epilepsy, Temporal Lobe; Lithium; Long-Term Potentiation; Male; Pilocarpine; Pyrroles; Quinazolines; Rats, Wistar; Receptor, PAR-1; Status Epilepticus | 2019 |
P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage.
Topics: Amygdala; Animals; Animals, Newborn; Bumetanide; Cell Death; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Female; Hippocampus; Kainic Acid; Male; Purinergic P2X Receptor Antagonists; Pyridines; Quinazolines; Rats; Rats, Sprague-Dawley; Sodium Potassium Chloride Symporter Inhibitors; Status Epilepticus; Tetrazoles | 2014 |
Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.
Topics: Animals; Body Weight; CA1 Region, Hippocampal; Male; Pyrroles; Quinazolines; Rats; Rats, Wistar; Receptor, PAR-1; Status Epilepticus; Thrombin | 2015 |
Effects of protease-activated receptor 1 inhibition on anxiety and fear following status epilepticus.
Topics: Animals; Anxiety; Epilepsy, Temporal Lobe; Fear; Male; Pilocarpine; Pyrroles; Quinazolines; Rats; Rats, Wistar; Receptor, PAR-1; Status Epilepticus | 2017 |
Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.
Topics: 5'-Nucleotidase; Adenosine; Animals; Dentate Gyrus; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; In Situ Nick-End Labeling; Male; Neuronal Plasticity; Neuroprotective Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Status Epilepticus; Synapses; Triazoles; Xanthines | 2005 |